#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Interstitial lung disease Hypertriglyceridaemia Haemophilia B without inhibitors Mucopolysaccharidosis I B-cell lymphoma refractory Primary mediastinal large B-cell lymphoma Craniocerebral injury Cerebral arteriovenous malformation haemorrhagic Marginal zone lymphoma refractory IgA nephropathy C3 glomerulopathy Acute respiratory distress syndrome Oesophageal adenocarcinoma Extranodal marginal zone B-cell lymphoma (MALT type) Glomerulonephritis minimal lesion More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Diagnostics Rett syndrome – Diagnostics Pituitary-dependent Cushing’s syndrome Paroxysmal nocturnal haemoglobinuria Synovial sarcoma – Treatment Gaucher’s disease type III – Treatment Alveolar rhabdomyosarcoma – Trials in Disease Haemolytic uraemic syndrome – Treatment Ornithine transcarbamoylase deficiency – Trials in Disease Small intestine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acp-017 Buloxibutid Cemiplimab Nebivolol Hydrochloride Isoprenaline Hydrochloride [18F]Fluoro-Peg-Folate FG001 Cloxacillin Keto-Leucine Calcium Cefixime Metoclopramide Hydrochloride Acoramidis Hydrochloride Mycophenolate Sodium Sabirnetug Pd01B Mercaptopurine Monohydrate Daridorexant Leuprorelin Ethanol, Anhydrous Febuxostat Hemihydrate More therapies…

    Learn about Your Condition

    Pancoast's tumour Dementia with Lewy bodies Gout Lymphocytic lymphoma Suicidal ideation Pneumonia Osteotomy Transplantation complication Dizziness Arginase deficiency Nicotine dependence Diphtheria Biliary adenoma Pertussis Shock More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic fatigue syndrome

  • Modafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    Investigated Drugs:
    • Modafinil
    • Placebo
    The Netherlands

  • Study on Daratumumab for Reducing Symptoms in Patients with Moderate to Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Recruiting

    2 1 1
    Investigated Drugs:
    • HYALURONIDASE
    • Daratumumab
    Norway

  • Study on Safinamide and Rasagiline for Treating Fatigue in Parkinson’s Disease Patients on Stable Dopaminergic Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    • Parkinson’s disease
    Investigated Drugs:
    • Rasagiline
    • Safinamide
    Spain

  • Study of Pregabalin Treatment and Rehabilitation for Chronic Fatigue in Post-COVID Syndrome Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Pregabalin
    Poland

  • Study of Daratumumab Injections for Patients with Moderate to Severe Chronic Fatigue Syndrome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    Investigated Drugs:
    • Daratumumab
    Norway

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!